Li Ou
Company: Avirmax Inc.
Job title: vp
Seminars:
Reducing AAV Immunogenicity Through Capsid Engineering 11:00 am
Analyzing the role of inverted terminal repeat regions in gene therapy immunogenicity Engineering ITRs to enhance AAV specificity and reduce dosage Modifying ITRs to evade immune recognition and increase the durability of expressionRead more
day: Conference Day One